Compugen Ltd.

Regulatory Filings • Dec 17, 2025

_________ false

�������� ��"�	2 381
COMPUGEN LTD
Corporation no: 511779639	15525
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	17/12/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-100732	Time of broadcast: 13:38 13:38

---

The corporation scheduled the publication of the report to 17/12/2025 14:00Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	�������'� ���� ���������� �� ��� �������� ������� �� Rilvegostomig �-AstraZeneca ����� �� �� �� 90 ������ ����

Press_Release_Monetized_Royalties_FINAL_EN_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: TASE	Date of revision of form structure: 06/08/2024
Address: Harokmim 26 , Holon 5885849   , Tel: 03-7658585 , 03-7658525 Fax: 03-7658555
E-mail address: eranbd@cgen.com
Previous names of reporting entity:
Name of the Signatory: Silberman David Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Harokmim St. 26 , Holon 5885849 Telephone: 03-7658585 Facsimile: 03-7658555 E-mail: davids@cgen.com 1